Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
180 Life Sciences Corp. | Director | Common Stock | 24.4K | $4.59K | $0.19 | Sep 4, 2023 | Direct |
180 Life Sciences Corp. | Director | Non-Qualified Stock Option (right to buy) | 15K | Sep 4, 2023 | Direct | ||
MERRIMACK PHARMACEUTICALS INC | Director | Common Stock | 0 | $13.35 | Dec 31, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ATNF | 180 Life Sciences Corp. | Sep 4, 2023 | 2 | $29.2K | 4 | Sep 8, 2023 | Director |
ATNF | 180 Life Sciences Corp. | Oct 31, 2022 | 1 | $0 | 4 | Nov 2, 2022 | Director |
ATNF | 180 Life Sciences Corp. | Jul 27, 2022 | 1 | $0 | 4 | Jul 29, 2022 | Director |
ATNF | 180 Life Sciences Corp. | May 19, 2022 | 2 | $14.4K | 4/A | Jul 29, 2022 | Director |
ATNF | 180 Life Sciences Corp. | Jan 14, 2022 | 1 | $14.4K | 4 | Jan 18, 2022 | Director |
MACK | MERRIMACK PHARMACEUTICALS INC | Dec 31, 2021 | 1 | -$3.84K | 4 | Jan 4, 2022 | Director |
ATNF | 180 Life Sciences Corp. | Aug 4, 2021 | 1 | $0 | 4 | Aug 5, 2021 | Director |
ATNF | 180 Life Sciences Corp. | Jul 9, 2021 | 0 | $0 | 3 | Jul 12, 2021 | Director |
MACK | MERRIMACK PHARMACEUTICALS INC | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |